Abstract
Introduction

Inflammatory pseudotumor of the lung is a rare disease that most often affects children and young adults (1). It consists of a spectrum of fibroblastic or myofibrotic proliferations with a varying infiltrate of inflammatory cells, including plasma cells, lymphocytes, and histiocytes. Multiple synonyms, such as plasma cell granuloma or inflammatory myofibroblastic tumor, have been utilized. In this context, inflammatory pseudotumor is very likely composed of multiple distinct entities with differing etiology, ranging from reactive proliferation to low-grade neoplasm (2).
The natural history of inflammatory pseudotumor of the lung is extremely diverse. The lesions are usually solitary and well-circumscribed masses. Most of the lesions remain stable in size or grow slowly, but some of them invade local mediastinal structures or the chest wall (3) (4) (5) (6) . The disease can relapse, be multifocal and give distant metastases (6) .
The standard procedure, for both diagnosis and treatment, is surgical excision (3) (4) (5) (6) . The prognosis of patients who underwent complete surgical resection has been reported to be excellent (5, 6) (Fig. 1C) . Gallium scintigraphy was not examined. A video-assisted thoracoscopic biopsy was performed. Pathological evaluation showed prominent plasma cell infiltration with intra-alveolar organization (Fig. 2B) . Some of the plasma cells were IgG4-positive (Fig. 2D) (15) . The association of IgG4 dysregulation and inflammatory pseudotumor was first reported in sclerosing pancreatitis (16) . IgG4 is the least abundant of the IgG subclasses, accounting for less than 6% of the total IgG fraction in the serum of a healthy subject (17) . Serum IgG4 is elevated in the limited number of conditions such as atopic dermatitis and pemphigus vulgaris (18, 19 (21) .
F i g u r e 1 . S e r i a l CT s c a n s o f t h e c h e s t . ( A) A h e mi -s p h e r i c a l ma s s i n t h e r i g h t l o we r l o b e c o n t i g uo u s t o r e ma r k a b l e p l e u r a l t h i c k e n i n g wa s s e e n i n J a n u a r y 1 9 9 3 . P l e u r a l c a l c i f i c a t i o n wa s a l s o p r es e n t d u e t o o l d t u b e r c u l o s i s . ( B ) B o t h t h e ma s s a n d p l e u r a l t h i c k e n i n g s h r a n k s u b s t a n t i a l l y a f t e r s t e r o i d t h e r a p y . ( C) A n e w c o n s o l i d a t i o n o c c u r r e d i n t h e r i g h t mi d d l e l o b e i n c o n t a c t wi t h t h e
F i g u r e 2 . Mi c r o s c o p i c e x a mi n a t i o n o f t h e l u n g ma s s e s r e s e c t e d i n 1 9 9 3 ( A) a n d i n 2 0 0 6 ( B ) r ev e a l e d a n i n t r a -a l v e o l a r o r g a n i z a t i o n wi t h l y mp h o p l a s ma c y t i c i n f i l t r a t e s ( He ma t o x y l i n E o s i n s t a i ni n g , o r i g i n a l ma g n i f i c a t i o n , × 1 0 0 ) . I mmu n o h i s t o c h e mi c a l s t u d i
Discussion
Inflammatory pseudotumor may arise at any anatomical site, and is considered to be composed of a variety of etiological entities ranging from inflammation to neoplasm (2). Some researchers regard it as a true neoplasm because of the tendency for local recurrence and the presence of ALK gene rearrangement on chromosome 2p23 in a subset of inflammatory myofibroblastic tumors (11). The ALK gene encodes for a receptor tyrosine kinase, and ALK gene rearrangements were first documented in anaplastic large cell lymphoma (12). The ALK abnormality generally leads to ALK protein overexpression and is detectable by immunohistochemistry. Although our patient had recurrence, immunohistochemistry for ALK protein was negative. In contrast, other investigators believe that inflammatory pseudotumor is an immunologic response to an infectious or non-infectious insult (13). A history of antecedent infection was present in approximately one-third of the reported cases (14). Recently, immunohistochemical studies have suggested that IgG4-related immunopathologic process is likely involved in the pathogenesis of inflammatory pseudotumor
Several reports have demonstrated the efficacy of steroid therapy to inflammatory pseudotumor of the lung (7) (8) (9) (10) 
